BioQuad Recalls Two OsteoDenx Lots for Undeclared Milk, Adds Amazon UPCs to Notice
Smartor 편집팀
November 15, 2026
AI-generated illustration of supplement capsules and packaging; not a photograph of a recalled product.
Yorba Linda, California-based bioQuad Life Sciences is recalling two lots of OsteoDenx dietary supplement capsules because their packaging does not declare milk. The company updated its Nov. 13 recall notice on Nov. 14 to identify additional UPC product codes used for packages sold on Amazon.
According to the company announcement published by the U.S. Food and Drug Administration on Nov. 13, the capsules contain lactoferrin derived from cow’s milk. The labeling issue was discovered during a routine FDA inspection. The company said people with a milk allergy or severe sensitivity could experience a serious or life-threatening allergic reaction. No illnesses had been reported at the time of the notice.
Nationwide distribution of 30- and 60-capsule cartons
The recall covers 30- and 60-capsule paperboard cartons bearing lot numbers 0524100 and 0625041, with expiration dates of May 2027 and August 2028, respectively. The products reached consumers nationwide from Nov. 1, 2024, through Nov. 11, 2026, through online orders at the company’s website and Amazon, resellers, and a dental clinic in Redwood City, California.
The Nov. 13 notice posted by the FDA lists UPC 857294007228 for the 30-capsule carton and 857294007341 for the 60-capsule carton. The manufacturer’s own notice, updated Nov. 14, separately lists Amazon-sold 30-capsule cartons under UPC 857294007259 and 60-capsule cartons under UPC 857294007242. Those Amazon entries carry the same two lot numbers and expiration dates.
A comparison of the notices shows two additional Amazon UPCs in the manufacturer’s latest product list, while the number of recalled lots remains two. The company did not specify the total number of affected cartons.
Distribution halted pending corrected packaging
The company said distribution has stopped until corrected cartons are available. The recall is being conducted with the FDA’s knowledge. The manufacturer’s notice did not give a date for distribution to resume in corrected packaging.